Edición/Edição: 2ª Autores:Kwan-Leung Chan; John M. Embil Editorial:Springer ISBN: 9783319277820 Formato: Rústica/Paperback Nº volumenes: 1 Páginas: 412 Año publicación/Ano de publicação: 2016 Disponibilidad/Disponibilidade: 15 días Precio/Preço
:146,99 €145,23 €(139,64€ + iva)
(Sea el primero en opinar
) ¿Vas a pedir más de 5 productos? Escríbenos, te enviaremos presupuesto ajustado, envíanos mail
This new addition will provide an update on the current prophylaxis guidelines, the new diagnostic approach in the detection of the disease, the proposed schemas to predict prognosis, and the new treatment strategies to improve the outcome of patients afflicted with this serious condition. Endocarditis is a serious disease with a high rate of morbidity and mortality. The in-hospital mortality remains at 10-20%. The poor outcome of patients with this condition is due in large part to the delay in making the diagnosis which frequently can be elusive. As a result of its wide spectrum of manifestations, endocarditis can mimic many different conditions ranging from stroke to renal failure. In order to minimize the delay in diagnosis, clinicians need to always be mindful of the possibility that endocarditis may be the cause of the symptoms. There have been ongoing efforts in the development of molecular probes and new imaging techniques to improve our ability to identify the disease early and reliably. New treatment strategies have been studied with the aim to prevent complications and to improve survival. The structure of the previous edition is preserved. The book is divided into three sections with the first section covering the historical perspective and basic principles, the second section dealing with the diagnosis and management approaches and the last section on specific clinical situations that pose management dilemmas. All the chapters will be updated to include new information from the recent studies. In particular, the approach to the use of antibiotic prophylaxis will be extensively revised to present and discuss the implications of the current guidelines from different national societies including the American Heart Association and the British Society for Antimicrobial Chemotherapy. This update is timely and should be of interest to all clinicians involved in the care of patients with this serious disease. This new edition will be a good resource for internists, infectious disease specialists, cardiologists and cardiac surgeons alike. Dr. Kwan Chan is a cardiologist at the University of Ottawa Heart Institute and Professor of Medicine at the University of Ottawa. He earned a BSc, MSc and his medical degree from the University of Manitoba, Winnipeg, Manitoba. Dr. Chan was certified as a Fellow of the Royal College of Physicians and Surgeons of Canada in Internal Medicine (1983) and Cardiology (1984). He is currently the Director of the Echocardiography Laboratory. His research interests include valvular heart disease, infective endocarditis and aortic diseases. He has a special interest in the application of ultrasound in the study of cardiac structure and function and has been actively involved in CME in this area.